Journal of Pharmacy Practice · 2015 · 29 citations · 26 references
MedicinePharmacologyClinical PharmacologyPharmacovigilancePsychopharmacologyAdverse Drug Event DetectionAdverse Drug Reaction DetectionAdverse Drug Reaction ReportingAdverse Drug ReactionsDelirium AssessmentDelirium In Critical IllnessAdverse Drug EventsAntipsychotic Medication UseAntipsychotic Use In DeliriumDelirium Severity AssessmentHarm AssessmentSerious Adverse Drug Reactions
PURPOSE: This investigation evaluated the incidence, severity, and harm of adverse drug reactions (ADRs) associated with antipsychotic use for intensive care unit (ICU) delirium. METHODS: In this prospective, observational study patients were screened for development of delirium with the Intensive Care Delirium Screening Checklist (ICDSC). An ICDSC score of ≥4 was considered delirious. Patients with delirium were screened daily for ADRs. Suspected ADRs were evaluated for drug causality using 3 published, objective assessment tools. Suspected ADRs were considered positive when 2 of 3 instruments had an agreement rating of "possible" or greater. ADR severity was defined as "mild/moderate" or "severe" using the National Cancer Institute's Common Terminology Criteria for Adverse Events scale. A modified National Coordinating Council Medication Error Reporting Index for Categorizing Errors categorized ADRs into "no harm" or "harmful." RESULTS: Of 90 patients with delirium, 56 received antipsychotics. Ten suspected ADRs occurred attributed to antipsychotic use. QTc prolongation was the most observed ADR (50%). Patients with ADRs had higher mean Acute Physiology and Chronic Health Evaluation II (APACHE II) scores (P = .038). Patients who received haloperidol experienced more severe (P = .048) ADRs. CONCLUSIONS: ADRs were observed in 18% of patients having delirium treated with antipsychotics with about half considered severe or harmful. A risk versus benefit assessment is needed before initiating antipsychotic therapy in ICU patients.
26
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Adverse drug reactions: definitions, diagnosis, and management
I. Ralph Edwards, Jeffrey K Aronson · The Lancet · 2000 · 3K citations
Incidence, risk factors and consequences of ICU delirium
Sébastien Ouimet, Brian P. Kavanagh, Stewart B. Gottfried et al. · Intensive Care Medicine · 2006 · 981 citations